naltrexone has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.13) | 18.2507 |
2000's | 17 (53.13) | 29.6817 |
2010's | 13 (40.63) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Hamzaoui, S; Kebir, O; Laqueille, X; Mouaffak, F | 1 |
Astrup, A; Christensen, R; Johansen, KGV; Lund, H; Pagsberg, AK; Tarp, S | 1 |
Jahn, I; Olbrich, S; Stengler, K | 1 |
Spada, MM | 1 |
Duda, JE; Hurtig, H; Minger, J; Papay, K; Siderowf, A; Stern, M; Weintraub, D; Xie, SX | 1 |
Galduróz, JC; Ramos, AC; Santos-Galduróz, RF | 1 |
Groves, M; Liang, JW; Shanker, VL | 1 |
Papay, K; Weintraub, D; Xie, SX | 1 |
Berendse, HW; Nelis, EA; van den Heuvel, OA | 1 |
Fontenelle, LF; Piquet-Pessôa, M | 1 |
Allen, AR; Balleine, B; Carter, A; Clark, L; Dowling, NA; Gainsbury, SM; Goudriaan, AE; Grant, J; Hall, W; Hayes, A; Hodgins, D; Lattimore, R; Livingstone, C; Lorenzetti, V; Lubman, D; Murawski, C; Parkes, L; Petry, N; Room, R; Singh, B; Thomas, A; Townshend, P; van Holst, R; Youssef, G; Yücel, M | 1 |
Gorelick, DA; Gottheil, E; Mannelli, P; Patkar, AA; Peindl, K; Wu, LT | 1 |
Blanco, C; Grant, JE; Hollander, E; Kim, SW; Potenza, MN | 1 |
Grant, JE; Kim, SW; Odlaug, BL | 1 |
Coleman, E; Grant, JE; Raymond, NC | 1 |
Carminati, GG; Deriaz, N; Orihuela-Flores, M | 1 |
Belkız Güngör, B; Çetinay Aydın, P; Gülseren, L | 1 |
Kozian, R; Otto, FG | 1 |
Grant, JE; Grosz, R | 1 |
Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E | 1 |
Cunningham-Williams, R; Grant, JE; Hollander, E; Kallio, A; Nurminen, T; Potenza, MN; Smits, G | 1 |
Grant, JE | 1 |
Hutchison, KE; Kaplan, GB; MacKinnon, SV; Monti, PM; Rohsenow, DJ; Sirota, AD; Swift, RM | 1 |
Grant, JE; Hartman, BK; Kim, SW | 1 |
Kim, SW | 1 |
Buchalter, AJ; DeCaria, CM; Hollander, E | 1 |
Adson, DE; Grant, JE; Kim, SW; Shin, YC | 1 |
Grant, JE; Kim, SW | 5 |
9 review(s) available for naltrexone and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders | 2017 |
An overview of problematic internet use.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Internet; Methylphenidate; Mood Disorders; Naltrexone; Narcotic Antagonists; Prevalence; Substance-Related Disorders | 2014 |
[Hypersexuality and other impulse control disorders in Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease; Sexual Dysfunction, Physiological; Treatment Outcome | 2016 |
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania | 2016 |
Neuroscience in gambling policy and treatment: an interdisciplinary perspective.
Topics: Administrative Personnel; Appetite Depressants; Decision Making; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Harm Reduction; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neurosciences; Public Health | 2017 |
[Pharmacological treatment of kleptomania--review].
Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Pharmacological treatments of pathological gambling.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Fluvoxamine; Gambling; Humans; Naltrexone; Outcome Assessment, Health Care; Paroxetine; Piperazines; Research Design; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazoles | 2005 |
Understanding and treating kleptomania: new models and new treatments.
Topics: Algorithms; Cognitive Behavioral Therapy; Combined Modality Therapy; Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Recurrence | 2006 |
Pathological gambling.
Topics: Cognitive Behavioral Therapy; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Male; Mental Disorders; Naltrexone; Narcotic Antagonists; Residential Treatment; Selective Serotonin Reuptake Inhibitors; Self-Help Groups | 2000 |
10 trial(s) available for naltrexone and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring.
Topics: Aged; Disruptive, Impulse Control, and Conduct Disorders; Female; Galvanic Skin Response; Humans; Implosive Therapy; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2019 |
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
Topics: Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease | 2014 |
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.
Topics: Adult; Analgesics, Opioid; Community Mental Health Services; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inactivation, Metabolic; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Program Development; Substance Withdrawal Syndrome | 2009 |
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Follow-Up Studies; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Personality Inventory; Psychometrics; Reproducibility of Results | 2009 |
A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
Topics: Adolescent; Adult; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Severity of Illness Index; Theft | 2009 |
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Topics: Adult; Age of Onset; Ambulatory Care; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2006 |
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Pressure; Breath Tests; Capsules; Carbon Monoxide; Demography; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tablets | 2007 |
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Topics: Adolescent; Adult; Aged; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 2008 |
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Gambling; Humans; Interview, Psychological; Liver Function Tests; Middle Aged; Naltrexone; Narcotic Antagonists; Single-Blind Method; Surveys and Questionnaires | 2001 |
An open-label study of naltrexone in the treatment of kleptomania.
Topics: Adult; Ambulatory Care; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Sex Factors; Single-Blind Method; Treatment Outcome | 2002 |
13 other study(ies) available for naltrexone and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Kleptomania treated with naltrexone in a patient with intellectual disability
Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists | 2020 |
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease | 2015 |
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease | 2015 |
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease | 2015 |
Augmentation with naltrexone to treat compulsive sexual behavior: a case series.
Topics: Adult; Comorbidity; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Humans; Liver Function Tests; Male; Mental Disorders; Middle Aged; Minnesota; Naltrexone; Narcotic Antagonists; Retrospective Studies; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 2010 |
Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: a case report.
Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2010 |
Naltrexone treatment of kleptomania: a case report.
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluoxetine; Humans; Naltrexone; Obsessive-Compulsive Disorder | 2012 |
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation.
Topics: Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Personality Assessment; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Opioid antagonists in the treatment of impulse-control disorders.
Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 1998 |
An open naltrexone treatment study in pathological gambling disorder.
Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Personality Assessment; Psychiatric Status Rating Scales; Treatment Outcome | 2001 |
Demographic and clinical features of 131 adult pathological gamblers.
Topics: Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Socioeconomic Factors | 2001 |
A case of kleptomania and compulsive sexual behavior treated with naltrexone.
Topics: Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Sexual Behavior; Treatment Outcome | 2001 |
Adolescent kleptomania treated with naltrexone--a case report.
Topics: Adolescent; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Naltrexone; Narcotic Antagonists; Time Factors; Treatment Outcome | 2002 |